Berenberg Bank restated their hold rating on shares of Smith & Nephew plc (LON:SN) in a report released on Tuesday, MarketBeat.com reports. The brokerage currently has a GBX 1,300 ($16.98) price target on the stock.
Several other equities analysts have also recently issued reports on the company. Numis Securities Ltd reiterated an add rating and issued a GBX 1,350 ($17.63) price objective on shares of Smith & Nephew plc in a research note on Friday, May 5th. Jefferies Group LLC reiterated a buy rating and issued a GBX 1,350 ($17.63) price objective on shares of Smith & Nephew plc in a research note on Wednesday, March 29th. Shore Capital reiterated a hold rating and issued a GBX 1,144 ($14.94) price objective on shares of Smith & Nephew plc in a research note on Friday, May 5th. HSBC Holdings plc reiterated a hold rating and issued a GBX 1,320 ($17.24) price objective on shares of Smith & Nephew plc in a research note on Wednesday, April 26th. Finally, Deutsche Bank AG reiterated a hold rating and issued a GBX 1,200 ($15.67) price objective on shares of Smith & Nephew plc in a research note on Tuesday, April 25th. One analyst has rated the stock with a sell rating, eleven have given a hold rating and three have given a buy rating to the company. The company has an average rating of Hold and a consensus price target of GBX 1,272.14 ($16.61).
Shares of Smith & Nephew plc (LON:SN) opened at 1336.00 on Tuesday. Smith & Nephew plc has a 1-year low of GBX 1,064.91 and a 1-year high of GBX 1,387.89. The company has a 50-day moving average of GBX 1,342.14 and a 200-day moving average of GBX 1,267.55. The stock’s market capitalization is GBX 11.68 billion.
WARNING: “Berenberg Bank Reaffirms Hold Rating for Smith & Nephew plc (LON:SN)” was first reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece on another site, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The original version of this piece can be read at https://stocknewstimes.com/2017/07/21/berenberg-bank-reaffirms-hold-rating-for-smith-nephew-plc-lonsn.html.
Smith & Nephew plc Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with MarketBeat.com's FREE daily email newsletter.
